What Nephrolopathologists Need to Know About Antiphospholipid Syndrome-Associated Nephropathy: Is It Time for Formulating a Classification for Renal Morphologic Lesions? Publisher



Mubarak M¹ ; Nasri H²
Source: Journal of Nephropathology Published:2014

Abstract

Context: Antiphospholipid syndrome (APS) is a systemic autoimmune disorder which commonly affects kidneys. Evidence Acquisitions: Directory of Open Access Journals (DOAJ), Google Scholar, PubMed (NLM), LISTA (EBSCO) and Web of Science have been searched. Results: There is sufficient epidemiological, clinical and histopathological evidence to show that antiphospholipid syndrome is a distinctive lesion caused by antiphospholipid antibodies in patients with different forms of antiphospholipid syndrome. It is now time to devise a classification for an accurate diagnosis and prognostication of the disease. Conclusions: Now that the morphological lesions of APSN are sufficiently well characterized, it is prime time to devise a classification which is of diagnostic and prognostic utility in this disease. © 2014, Society of Diabetic Nephropathy Prevention. All rights reserved.